- Citations, last 5 years
- 72
- Works, last 5 years
- 7
- h-index
- 30
- Scientists listed
- 2
- Grants since 2016
- 9
Grants received
2022–2026 · research · INNO-NAERING-Inno-naering brukerstyrte prosjekter
TARRGET - Targeting Alginates to Resistant and Recurrent Infections: Generating Eradication Therapies
Milda Kaniusaite · AlgiPharma (Norway) · funded by Norges Forskningsråd
2021 · research · PES-HORISONT-EU-PES Horisont Europa
The Rapid commercialization of an AlgiNate therapy for reSPIRatory diseasEs - TRANSPIRE
Philip Rye · AlgiPharma (Norway) · funded by Norges Forskningsråd
2020 · research · PES2020-Prosj.etabl.støtte H2020
Project Establishment Support for EIC Accelerator application
Ove Alexander Høgmoen Åstrand · AlgiPharma (Norway) · funded by Norges Forskningsråd
2020–2026 · research · INNO-NAERING-Inno-naering brukerstyrte prosjekter
Algi-SCALEUP: Fermentation Scaleup for Manufacturing of Pharmaceutical Alginate Oligosaccharides
Milda Kaniusaite · AlgiPharma (Norway) · funded by Norges Forskningsråd
2019–2022 · research · BEHANDLING-God og treffsikker diagnostikk, behandling og rehabilitering
Strengthening of H2020-funded project "OligoGpivotalCF"
Ove Alexander Høgmoen Åstrand · AlgiPharma (Norway) · funded by Norges Forskningsråd
2018–2022 · research · H2020 - RIA
A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis
AlgiPharma (Norway) · funded by European Commission
2018–2021 · research · BIA-Brukerstyrt innovasjonsarena
Production of alginate oligomers for medical use (Oligo-DSP)
Ove Alexander Høgmoen Åstrand · AlgiPharma (Norway) · funded by Norges Forskningsråd
2018–2023 · research · NANO2021-Nanoteknologi, nanovitenskap, mikroteknologi og avanserte materialer
Novel Alginate Oligomer Products for Enhanced Pharmaceutical Delivery Across Mucosal Barriers
Philip Rye · AlgiPharma (Norway) · funded by Norges Forskningsråd
2017 · research · PES2020-Prosj.etabl.støtte H2020
PES2020; A pivotal phase III clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis
Are Kristiansen · AlgiPharma (Norway) · funded by Norges Forskningsråd